Breakthrough Therapy Cancer Drugs and Indications With FDA Approval: Development Time, Innovation, Trials, Clinical Benefit, Epidemiology, and Price
CONCLUSIONS: The BTD expedites patient access to effective and innovative, but also expensive, new cancer drugs and indications.PMID:38648855 | DOI:10.6004/jnccn.2023.7110
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Authors: Daniel Tobias Michaeli Thomas Michaeli Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Epidemiology | Medicaid | Medicare | Study